Skip to main content

Search

Reset all filters
525 Result(s)
Sort by

Corporate Profile

Corporate Profile

Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim.
Hypertension

Hypertension

Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke.
COVID-19

COVID-19

Boehringer Ingelheim is engaged at various levels of action to contain and cope with the global spread of COVID-19.
Retinal Diseases

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Skin Diseases

Skin Diseases

We discover and develop breakthrough therapies that can be used to prevent, treat and repair many inflammatory and fibrotic diseases.
Gastrointestinal Cancers

Gastrointestinal Cancers

Our aim is to give hope and commitment to patients suffering from Gastrointestinal Cancer. Click here to access GI resources, advice and useful links.
Our Commitment

Our Commitment

View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better.
Atrial Fibrillation

Atrial Fibrillation

At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots.